GLAB — Gemina Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00- CA$36.66m
- CA$37.16m
Annual cashflow statement for Gemina Laboratories, fiscal year end - January 31st, CAD millions except per share, conversion factor applied.
2021 January 31st | 2022 January 31st | 2023 January 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -0.834 | -4.73 | -5.98 |
| Depreciation | |||
| Non-Cash Items | 0.363 | 0.706 | 0.403 |
| Other Non-Cash Items | |||
| Changes in Working Capital | 0.14 | 0.113 | 1.02 |
| Change in Accounts Receivable | |||
| Change in Prepaid Expenses | |||
| Change in Payable / Accrued Expenses | |||
| Cash from Operating Activities | -0.319 | -3.87 | -4.51 |
| Capital Expenditures | — | -0.01 | -0.08 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | 0.014 | 0.018 | -0.425 |
| Sale of Business | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | 0.014 | 0.008 | -0.505 |
| Financing Cash Flow Items | 0.512 | 1.59 | 2.78 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 1.19 | 4.14 | 3.94 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 0.882 | 0.274 | -1.07 |